Cingulate Valuation
| CING Stock | USD 5.74 0.02 0.35% |
At this time, the firm appears to be overvalued. Cingulate shows a prevailing Real Value of $4.35 per share. The current price of the firm is $5.74. Our model approximates the value of Cingulate from analyzing the firm fundamentals such as Return On Equity of -2.76, current valuation of 41.05 M, and Shares Owned By Insiders of 1.38 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cingulate's price fluctuation is unstable at this time. Calculation of the real value of Cingulate is based on 3 months time horizon. Increasing Cingulate's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cingulate stock is determined by what a typical buyer is willing to pay for full or partial control of Cingulate. Since Cingulate is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cingulate Stock. However, Cingulate's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.74 | Real 4.35 | Hype 5.74 | Naive 5.58 |
The real value of Cingulate Stock, also known as its intrinsic value, is the underlying worth of Cingulate Company, which is reflected in its stock price. It is based on Cingulate's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cingulate's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cingulate helps investors to forecast how Cingulate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cingulate more accurately as focusing exclusively on Cingulate's fundamentals will not take into account other important factors: About Cingulate Valuation
The stock valuation mechanism determines Cingulate's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cingulate. We calculate exposure to Cingulate's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cingulate's related companies.Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Complementary Tools for Cingulate Stock analysis
When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |